169 related articles for article (PubMed ID: 31672655)
1. Morphological quantification of proliferation-to-invasion transition in tumor spheroids.
He Y; Xiong L; Gao X; Hai M; Liu Y; Wang G; Chen G; Shuai J; Jiao Y; Zhang X; Liu R; Liu L
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129460. PubMed ID: 31672655
[TBL] [Abstract][Full Text] [Related]
2. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
3. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
4. A novel ex vivo tumor system identifies Src-mediated invasion and metastasis in mesenchymal tumor cells in non-small cell lung cancer.
Padhye A; Ungewiss C; Fradette JJ; Rodriguez BL; Albritton JL; Miller JS; Gibbons DL
Sci Rep; 2019 Mar; 9(1):4819. PubMed ID: 30894630
[TBL] [Abstract][Full Text] [Related]
5. Patterning hypoxic multicellular spheroids in a 3D matrix - a promising method for anti-tumor drug screening.
Ma J; Zhang X; Liu Y; Yu H; Liu L; Shi Y; Li Y; Qin J
Biotechnol J; 2016 Jan; 11(1):127-34. PubMed ID: 26647062
[TBL] [Abstract][Full Text] [Related]
6. Generation of 3D Tumor Spheroids with Encapsulating Basement Membranes for Invasion Studies.
Nazari SS
Curr Protoc Cell Biol; 2020 Jun; 87(1):e105. PubMed ID: 32436628
[TBL] [Abstract][Full Text] [Related]
7. Hybrid collagen alginate hydrogel as a platform for 3D tumor spheroid invasion.
Liu C; Lewin Mejia D; Chiang B; Luker KE; Luker GD
Acta Biomater; 2018 Jul; 75():213-225. PubMed ID: 29879553
[TBL] [Abstract][Full Text] [Related]
8. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
9. Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo.
Hu Y; Li S; Yang M; Yan C; Fan D; Zhou Y; Zhang Y; Yagüe E; Xiong D
Breast Cancer Res Treat; 2014 Jan; 143(2):287-99. PubMed ID: 24337682
[TBL] [Abstract][Full Text] [Related]
10. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
[TBL] [Abstract][Full Text] [Related]
12. In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening.
Benton G; DeGray G; Kleinman HK; George J; Arnaoutova I
PLoS One; 2015; 10(4):e0123312. PubMed ID: 25856378
[TBL] [Abstract][Full Text] [Related]
13. Scaffold stiffness influences breast cancer cell invasion via EGFR-linked Mena upregulation and matrix remodeling.
Berger AJ; Renner CM; Hale I; Yang X; Ponik SM; Weisman PS; Masters KS; Kreeger PK
Matrix Biol; 2020 Jan; 85-86():80-93. PubMed ID: 31323325
[TBL] [Abstract][Full Text] [Related]
14. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
15. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.
Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y
Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem-like cells with hybrid epithelial/mesenchymal phenotype leading the collective invasion.
Quan Q; Wang X; Lu C; Ma W; Wang Y; Xia G; Wang C; Yang G
Cancer Sci; 2020 Feb; 111(2):467-476. PubMed ID: 31845453
[TBL] [Abstract][Full Text] [Related]
17. An epigenetically distinct breast cancer cell subpopulation promotes collective invasion.
Westcott JM; Prechtl AM; Maine EA; Dang TT; Esparza MA; Sun H; Zhou Y; Xie Y; Pearson GW
J Clin Invest; 2015 May; 125(5):1927-43. PubMed ID: 25844900
[TBL] [Abstract][Full Text] [Related]
18. A truncated p53 in human lung cancer cells as a critical determinant of proliferation and invasiveness.
Li W; Lai B; Yang X; Zhang C; Wang H
Tumour Biol; 2017 Jun; 39(6):1010428317703824. PubMed ID: 28631571
[TBL] [Abstract][Full Text] [Related]
19. TASI: A software tool for spatial-temporal quantification of tumor spheroid dynamics.
Hou Y; Konen J; Brat DJ; Marcus AI; Cooper LAD
Sci Rep; 2018 May; 8(1):7248. PubMed ID: 29739990
[TBL] [Abstract][Full Text] [Related]
20. Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion.
Del Duca D; Werbowetski T; Del Maestro RF
J Neurooncol; 2004 May; 67(3):295-303. PubMed ID: 15164985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]